HOUSTON, TX--(Marketwired - Apr 9, 2013) - Sionix

New Post Public Reply Private Reply Replies (0) Message Board
testuser
HOUSTON, TX--(Marketwired - Apr 9, 2013) - Sionix Corporation (OTCQB: SINX) announced today the appointment of Dr. Henry W. Sullivan as its Chief Executive Officer and Chairman of the Sionix Board of Directors. Dr. Sullivan has been a Director of Sionix since October 2012 and he has been active in the technical and operating management of the company since that time. Dr. Sullivan holds both a Master's degree and Ph.D. in chemical engineering from New York University, and has held senior positions with Huntsman Petrochemical Corporation and Shell Oil Company for a combined 26 years, where his experience included the optimization of refineries and the allocation of hydrocarbons and their processing and movement. He founded and was CEO of several companies and has served on the Board of several public companies as well as the Sarkeys Energy Center at the University of Oklahoma. Coincident with the appointment of Henry Sullivan, Ken Calligar has resigned as interim CEO of Sionix and James W. Alexander has resigned as interim Chairman of the Board of Directors of the Company. Both Mr. Alexander and Mr. Calligar will continue to serve on the Sionix Board of Directors. Mr. Calligar stated, "We are very pleased to have Dr. Henry Sullivan leading Sionix. It is fortunate that someone of Henry's experience and capabilities is available to Sionix. In the past months we have collectively stabilized the company, revised its mission, strategies, and sales and services offerings. We have relocated the company to Houston to facilitate its focus on the oil and gas sector and we have eliminated wasteful policies and practices. This was a team effort. The next steps for Sionix are to establish a track record of its technologies and services. In order to do this, we have assembled an experienced and dedicated team, the appointments of whom we have previously announced. This leadership team, working with our technical staff, will pursue commercial opportunities in treating water produced in oil and gas fracking as well as agricultural, municipal and other water treating applications." Dr. Sullivan commented, "Our team is looking forward to extending the proprietary Sionix technology and to completing the final phase of pre-commercial testing in the Bakken shale in North Dakota. I have worked closely with Jim Alexander and Ken Calligar since I joined the Board and I am pleased that they will continue to help lead the Company as directors." About Sionix Corporation Sionix designs innovative and advanced water treatment systems intended for use in energy, government facilities, healthcare facilities, and emergency water supplies during natural disasters, housing development projects, and various industrial processes including subterranean fracturing used in oil and gas drilling. These systems can be located adjacent to contaminated water sites or as a pre-treatment for reverse osmosis and other membrane applications. Industries involved in dairy, agribusiness, meat processing, mining, poultry operations, and many others can benefit from Sionix' cost-effective, easily maintained, water treatment systems. For more information about the company, go to www.sionix.com. Forward-Looking Statements All statements in this press release that are not statements of historical fact are forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include, but are not limited to, whether Sionix Corporation can raise capital as and when it needs to, whether the water purification systems will generate significant sales, whether it can compete successfully in its market and industry, and other factors beyond the control of Sionix Corporation, including those detailed from time to time in the reports filed with the Securities and Exchange Commission. Sionix Corporation assumes no obligation and does not intend to update these forward-looking statements. Company Contact: Dr. Henry W. Sullivan Chief Executive Officerhsullivan@sionix.com

View More
Investors-Hangout-Stock-Message-Boards-thumbnail-2015.png

test123 kjk
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the Surge of the Air Cargo Market to USD 217.74 Billion

Updated Category News Views 33

Growth of the Air Cargo Market The air cargo market is on an exhilarating growth trajectory, anticipated to reach a staggering USD 217.74 billion in revenue. This expansion is propelled by several factors, chiefly the rising popularity of e-commerce and a globalized economy. As consumers increasingly turn to online shopping, the demand for swift and reliable delivery...

Continue Reading
Swiss National Bank Board Member Confirms Inflation Stability

Updated Category News Views 93

Swiss National Bank Board Insights on Inflation Trends Inflation has been a topic of concern for central banks worldwide, but recently, a representative from the Swiss National Bank (SNB), Petra Tschudin, shared some encouraging news regarding the current inflation climate. Current Inflation Rates and Expectations In October, inflation rates in Switzerland dropped to a...

Continue Reading
MindMed Initiates Phase 3 Study for MM120 in Anxiety Treatment

Updated Category News Views 326

MindMed Begins Journey with Phase 3 Study of MM120 Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has crossed a significant milestone in its mission to provide breakthrough treatments for brain health disorders. The clinical-stage biopharmaceutical company has announced that the first patient is now dosed in its pivotal Phase 3 Voyage study of MM120 Orally Disintegrating...

Continue Reading
William Silva Takes Charge of Mass Timber Initiatives at Swinerton

Updated Category News Views 177

William Silva Appointed as Director of National Mass Timber Swinerton Builders continues to enhance its mass timber capabilities with the recent appointment of William Silva as the Director of National Mass Timber. This decision emphasizes Swinerton's unwavering commitment to advancing mass timber construction, showcasing its leadership in the industry. Creating a Hub for...

Continue Reading
GlobalFoundries Teams Up with MIT for Semiconductor Breakthroughs

Updated Category News Views 95

GlobalFoundries and MIT's New Research Partnership In a significant development for the semiconductor industry, GlobalFoundries (NASDAQ: GFS) and the Massachusetts Institute of Technology (MIT) have embarked on an exciting collaboration aimed at enhancing the research and innovation surrounding essential chips for artificial intelligence (AI) and other critical...

Continue Reading